This company seems to have been delisted
Reason: Acquired by Novo Holdings
Last recorded trade on: February 19, 2025
Source: https://www.catalent.com/catalent-news/novo-holdings-completes-acquisition-of-catalent/
Reason: Acquired by Novo Holdings
Last recorded trade on: February 19, 2025
Source: https://www.catalent.com/catalent-news/novo-holdings-completes-acquisition-of-catalent/
Catalent
CTLT
£47.67
Share price
0.00%
Change (1 day)
6.89%
Change (1 year)
Categories
Catalent is an American pharmaceutical contract research and development company.
Earnings for Catalent (CTLT)
Earnings in 2024 (TTM): -£68.87 Million
According to Catalent's latest financial reports the company's current earnings are £4.42 Billion. In 2023 the company made an earning of -£0.91 Billion a decrease over its 2022 earnings that were of £0.48 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Catalent from 2013 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024 (TTM)  | -£68.87 Million | -92.4% |
| 2023 | -£0.91 Billion | -286.27% |
| 2022 | £0.48 B | -25.81% |
| 2021 | £0.65 B | 77.66% |
| 2020 | £0.36 B | 62.46% |
| 2019 | £0.22 B | 10.64% |
| 2018 | £0.20 B | 18.66% |
| 2017 | £0.17 B | 9.14% |
| 2016 | £0.15 B | -15.11% |
| 2015 | £0.18 B | 15.35% |
| 2014 | £0.16 B | 10.45% |
| 2013 | £0.14 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | £73.49 M | -207.55% | 🇺🇸 USA |
 | -£17.46 Million | -74.46% | 🇺🇸 USA |
 | £0.35 B | -616.87% | 🇮🇪 Ireland |
 | -£43.57 Million | -36.25% | 🇺🇸 USA |